569 results on '"Kotoula, Vassiliki"'
Search Results
2. Follow-up of tissue genomics in BRCA1/2 carriers who underwent prophylactic surgeries
3. Prothrombin complex concentrate in major bleeding associated with DOACs; an updated systematic review and meta-analysis
4. Tumor Infiltrating Lymphocytes and CD8+ T Cell Subsets as Prognostic Markers in Patients with Surgically Treated Laryngeal Squamous Cell Carcinoma
5. Prognostic impact of stromal and intratumoral CD3, CD8 and FOXP3 in adjuvantly treated breast cancer: do they add information over stromal tumor-infiltrating lymphocyte density?
6. Relapsed and De Novo Metastatic HER2-positive Breast Cancer Treated With Trastuzumab: Tumor Genotypes and Clinical Measures Associated With Patient Outcome
7. Pathogenic BRCA1 mutations may be necessary but not sufficient for tissue genomic heterogeneity: Deep sequencing data from ovarian cancer patients
8. Genetic mapping of pancreatic cancer by targeted next-generation sequencing in a cohort of patients managed with nab-paclitaxel-based chemotherapy or agents targeting the EGFR axis: a retrospective analysis of the Hellenic Cooperative Oncology Group (HeCOG)
9. Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer
10. Cyclin D1 differential activation and its prognostic impact in patients with advanced breast cancer treated with trastuzumab
11. Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.
12. Correlation of MYC Gene and Protein Status With Breast Cancer Subtypes and Outcome of Patients Treated With Anthracycline-Based Adjuvant Chemotherapy. Pooled Analysis of 2 Hellenic Cooperative Group Phase III Trials
13. Comparison of somatic variant detection algorithms using Ion Torrent targeted deep sequencing data
14. Primary Subcutaneous Spindle Cell Synovial Sarcoma: First Reported Case
15. Supplementary Data from Interactions of the Hdm2/p53 and Proteasome Pathways May Enhance the Antitumor Activity of Bortezomib
16. Supplemental Figure 2 from Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma
17. supplemental figure legend from Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma
18. Supplemental Figure 1 from Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma
19. Supplementary Tables S1 and S2 from Evaluation of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Laryngeal Squamous Cell Carcinoma
20. Molecular profile and clinical features of patients with gliomas using a broad targeted next generation‑sequencing panel
21. Investigation of prognostic biomarkers in patients with urothelial carcinoma treated with platinum-based regimens
22. Clinical Significance of Major Angiogenesis-Related Effectors in Patients with Metastatic Breast Cancer Treated with Trastuzumab-Based Regimens
23. Association of VEGF-A Splice Variant mRNA Expression With Outcome in Bevacizumab-Treated Patients With Metastatic Breast Cancer
24. The androgen receptor as a surrogate marker for molecular apocrine breast cancer subtyping
25. Prognostic significance of the Wnt pathway in squamous cell laryngeal cancer
26. Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe
27. Nodal mesenteric marginal zone lymphoma with amyloid deposits, calcification, and ossification
28. Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping
29. Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes
30. Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes
31. p85 Protein Expression is Associated with Poor Survival in HER2-Positive Patients with Advanced Breast Cancer Treated with Trastuzumab
32. Improved Outcome of High-Risk Early HER2 Positive Breast Cancer With High CXCL13-CXCR5 Messenger RNA Expression
33. A case–control study on the rs3130932 single nucleotide polymorphism in the OCT4B translation initiation codon in association with cancer state
34. mRNA expression of specific HER ligands and their association with clinical outcome in patients with metastatic breast cancer treated with trastuzumab
35. Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin
36. Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
37. mRNA expression of specific HER ligands and their association with clinical outcome in patients with metastatic breast cancer treated with trastuzumab
38. A phase I study of temozolomide and lapatinib combination in patients with recurrent high-grade gliomas
39. Global microRNA profiling in favorable prognosis subgroups of cancer of unknown primary (CUP) demonstrates no significant expression differences with metastases of matched known primary tumors
40. DARPP32, STAT5 and STAT3 mRNA Expression Ratios in Glioblastomas are Associated with Patient Outcome
41. Sample parameters affecting the clinical relevance of RNA biomarkers in translational breast cancer research
42. Tumor Genotyping and Homologous Recombination Repair Gene Variants in Patients With Epithelial Ovarian Cancer: Is Pathogenic Enough?
43. Clinical Significance of Major Angiogenesis-Related Effectors in Patients with Metastatic Breast Cancer Treated with Trastuzumab-based Regimens
44. Somatostatin receptor expression in non-medullary thyroid carcinomas
45. Genetic Variation in the Vascular Endothelial Growth Factor (VEGFA) Gene at rs13207351 Is Associated with Overall Survival of Patients with Head and Neck Cancer
46. An unusual case of biphenotypic, bigenotypic mature lymphoma
47. hTERT immunopositivity patterns in the normal brain and in astrocytic tumors
48. Androgen Receptor and PIM1 Expression in Tumor Tissue of Patients With Triple-negative Breast Cancer
49. Genotyping data of routinely processed matched primary/metastatic tumor samples
50. Genotype-phenotype associations in colorectal adenocarcinomas and their matched metastases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.